- Home
- CRIS vs TPCS Comparison
CRIS vs TPCS Comparison
Compare CRIS & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- TPCS
- Stock Information
- Founded
- CRIS 2000
- TPCS 1956
- Country
- CRIS United States
- TPCS United States
- Employees
- CRIS N/A
- TPCS N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- TPCS Metal Fabrications
- Sector
- CRIS Health Care
- TPCS Industrials
- Exchange
- CRIS Nasdaq
- TPCS Nasdaq
- Market Cap
- CRIS 22.9M
- TPCS 51.4M
- IPO Year
- CRIS 2000
- TPCS N/A
- Fundamental
- Price
- CRIS $1.82
- TPCS $5.35
- Analyst Decision
- CRIS Strong Buy
- TPCS
- Analyst Count
- CRIS 2
- TPCS 0
- Target Price
- CRIS $16.50
- TPCS N/A
- AVG Volume (30 Days)
- CRIS 75.9K
- TPCS 63.9K
- Earning Date
- CRIS 11-13-2025
- TPCS 08-21-2025
- Dividend Yield
- CRIS N/A
- TPCS N/A
- EPS Growth
- CRIS N/A
- TPCS N/A
- EPS
- CRIS N/A
- TPCS N/A
- Revenue
- CRIS $11,405,000.00
- TPCS $33,424,000.00
- Revenue This Year
- CRIS $1.41
- TPCS N/A
- Revenue Next Year
- CRIS $7.46
- TPCS N/A
- P/E Ratio
- CRIS N/A
- TPCS N/A
- Revenue Growth
- CRIS 12.24
- TPCS 3.78
- 52 Week Low
- CRIS $1.02
- TPCS $2.05
- 52 Week High
- CRIS $6.44
- TPCS $6.25
- Technical
- Relative Strength Index (RSI)
- CRIS 57.41
- TPCS 53.42
- Support Level
- CRIS $1.63
- TPCS $5.10
- Resistance Level
- CRIS $1.95
- TPCS $5.50
- Average True Range (ATR)
- CRIS 0.14
- TPCS 0.29
- MACD
- CRIS 0.03
- TPCS -0.05
- Stochastic Oscillator
- CRIS 61.76
- TPCS 39.87
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About TPCS TechPrecision Corporation Common stock
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.